Overview
This entry, listed under Orphanet code 182076, is classified as 'OBSOLETE' — meaning it is no longer considered a distinct, standalone diagnosis in current medical classification systems. Originally, it referred to a group of conditions involving both neurological and metabolic problems combined with intellectual disability linked to the X chromosome. Over time, as genetic testing improved, many of the conditions that were once grouped under this broad label have been reclassified into more specific diagnoses with known genetic causes. Because this is an obsolete grouping, patients who were previously given this label may now have a more precise diagnosis based on the specific gene involved. Conditions that may have fallen under this umbrella include various X-linked intellectual disability syndromes that also feature metabolic abnormalities, such as problems with how the body processes certain nutrients, amino acids, or other substances. Symptoms typically included intellectual disability of varying severity, developmental delays, seizures, abnormal muscle tone, and sometimes distinctive facial features or growth problems. If you or a family member was previously diagnosed under this category, it is strongly recommended to seek updated genetic testing and evaluation. Modern genetic tools like whole exome sequencing or gene panels can often identify the exact genetic cause, leading to a more specific diagnosis, better prognostic information, and potentially more targeted treatment options.
Key symptoms:
Intellectual disabilityDevelopmental delaysSeizures or epilepsyAbnormal muscle tone (too stiff or too floppy)Difficulty with speech and languageProblems with coordination or balanceUnusual facial featuresGrowth problemsBehavioral difficultiesMetabolic abnormalities found on blood or urine testsFeeding difficulties in infancyMovement disorders
X-linked recessive
Carried on the X chromosome; typically affects males more than females
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability.
Start the conversation →Latest news about OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability
No recent news articles for OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has my child had modern genetic testing such as whole exome sequencing to identify the specific cause?,Is there a more specific diagnosis that replaces this obsolete category for my child's condition?,Are there any targeted or metabolic treatments available for the specific genetic cause?,What therapies (speech, occupational, physical) should we start and how often?,What should I do if my child has a seizure or shows signs of a metabolic crisis?,Are there clinical trials or research studies that my child might be eligible for?,Should other family members, especially males, be tested for this genetic condition?
Common questions about OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability
What is OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability?
This entry, listed under Orphanet code 182076, is classified as 'OBSOLETE' — meaning it is no longer considered a distinct, standalone diagnosis in current medical classification systems. Originally, it referred to a group of conditions involving both neurological and metabolic problems combined with intellectual disability linked to the X chromosome. Over time, as genetic testing improved, many of the conditions that were once grouped under this broad label have been reclassified into more specific diagnoses with known genetic causes. Because this is an obsolete grouping, patients who were p
How is OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability inherited?
OBSOLETE: Syndromic neurometabolic disease with X-linked intellectual disability follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.